Get the Stockscreener App
8.20
0.86%
0.07
After Hours:
8.19
-0.010
-0.12%
Certara Inc stock is traded at $8.20, with a volume of 2.38M.
It is up +0.86% in the last 24 hours and up +14.37% over the past month.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
See More
Previous Close:
$8.13
Open:
$8.13
24h Volume:
2.38M
Relative Volume:
0.60
Market Cap:
$1.28B
Revenue:
$419.75M
Net Income/Loss:
$-15.10M
P/E Ratio:
-86.04
EPS:
-0.0953
Net Cash Flow:
$63.10M
1W Performance:
+1.23%
1M Performance:
+14.37%
6M Performance:
+13.42%
1Y Performance:
-27.18%
1-Day Range:
$8.06
$8.285
1-Week Range:
$6.332
$8.39
52-Week Range:
$4.45
$13.88
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
(415) 237-8272
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
8.20 | 1.21B | 419.75M | -15.10M | 63.10M | -0.0953 |
VEEV
Veeva Systems Inc
|
230.47 | 31.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
62.43 | 14.13B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.05 | 7.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
104.63 | 8.28B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
89.33 | 5.81B | 646.34M | -512.40M | 202.76M | -6.6871 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-27-26 | Downgrade | Craig Hallum | Buy → Hold |
| Jan-06-26 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Nov-21-25 | Initiated | Rothschild & Co Redburn | Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-29-25 | Initiated | Craig Hallum | Buy |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| May-08-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Sep-27-24 | Upgrade | UBS | Neutral → Buy |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
Certara Inc (CERT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Certara Inc (CERT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Certara Inc (CERT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Certara Inc (CERT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Certara Inc (CERT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CERT|Certara Inc|Price:7.510|Chg%:+0.400 - TradingKey
TradingKey - TradingKey
Certara Inc (CERT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Why Did CERT Stock Fall Today? - Stocktwits
Certara, Inc. (CERT) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Certara, Inc. (CERT) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Certara, Inc. (CERT) Earnings Dates, Call Summary & Reports - TipRanks
Certara, Inc. (CERT) Stock Forecasts - Yahoo! Finance Canada
Technical Reactions to CERT Trends in Macro Strategies - Stock Traders Daily
How Certara’s NVIDIA AI Partnership Could Reshape CERT’s Long-Term Drug Development Narrative - webull.com
Certara Inc. (CERT) Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesEarnings Sentiment Score - dars.gov.et
Certara Q1 2026 Earnings: EPS Falls Short of Estimates, Stock Edges HigherLong-Term Guidance - po-news-eg.net
Certara Inc. (CERT) Slides 4.8% as Shares Test Key Support LevelsCollar Trade - dars.gov.et
Certara files Form 3 for interim CFO Mohammed Faiz initial beneficial ownership statement - Bitget
Certara (CERT) interim CFO discloses stock, RSU and PSU holdings - Stock Titan
Certara to report Q2 2026 financial results on August 4 - scanx.trade
Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026 - The Manila Times
Certara sets Aug. 4 call to discuss second-quarter results - Stock Titan
BlackRock, Inc.'s Strategic Acquisition of Certara Inc. Shares - GuruFocus
Pomerantz investigates Certara investors over p... - Pluang
Dimensional Fund Advisors details Certara Inc (CERT) 3.9% ownership position - Stock Titan
Certara (CERT) Taps NVIDIA For AI Drug Development, Is It A Bargain? - Sahm
What Certara (CERT)'s NVIDIA BioNeMo Partnership Means For Shareholders - Sahm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc.CERT - PR Newswire
BlackRock (CERT) discloses 18.0M shares; 11.6% ownership reported - Stock Titan
AI Chips TodayCertara-NVIDIA Partnership Revolutionizes AI in Drug Development - Yahoo Finance
Certara partners with Nvidia to integrate AI agents into drug development platform - Investing.com UK
Nvidia Powers AI Agent Strategies for Certara, Silo PharmaNVIDIA (NASDAQ:NVDA) - Benzinga
Certara teams up with Nvidia to strengthen AI platform with BioNeMo toolkit (CERT) - Yahoo Finance
Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit - The Manila Times
Certara Accelerates Drug Discovery and Development With NVIDIA BioNeMo Agent Toolkit - 富途牛牛
Certara, Silo Pharma advance AI strategies with Nvidia initiatives - scanx.trade
Price to earnings forward of Certara, Inc. – HAM:700 - TradingView
Enterprise value to revenue forward of Certara, Inc. – NASDAQ:CERT - TradingView
Price to sales forward of Certara, Inc. – HAM:700 - TradingView
Certara Inc (NASDAQ: CERT) Share Price, CERT Stock News, CERT Share Price & Updates - Kalkine
Is Certara (CERT) Quietly Recasting Its Small-Cap Identity Around Biosimulation Advisory Leadership? - Yahoo Finance
Does Certara (CERT) Joining the Russell 2000 Recast Its Biosimulation Investment Narrative? - simplywall.st
CERT Q1 2026 Earnings: EPS Misses Estimates but Stock Rises 2.75%Share Dilution Risk - DonanımHaber
Trading the Move, Not the Narrative: (CERT) Edition - Stock Traders Daily
William Blair Maintains Certara(CERT.US) With Hold Rating - Moomoo
Should You Investigate Certara, Inc. (NASDAQ:CERT) At US$6.36? - Moomoo
Certara, Inc. (CERT) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Pomerantz investigates Certara after revenue drop and CFO exit - scanx.trade
Certara Inc. (CERT) Rallies 8.9% – Key Support and Resistance Levels in FocusDealer Positioning - dars.gov.et
Certara, Inc.(NasdaqGS: CERT) added to Russell 2000 Index - marketscreener.com
Certara Inc Stock (CERT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Certara Inc Stock (CERT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Corcoran Daniel | SVP and General Counsel |
Jun 01 '26 |
Option Exercise |
0.00 |
22,830 |
0 |
39,939 |
| Collins Cynthia | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
51,846 |
| Reynders John V W | Chief Financial Officer |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
26,466 |
| BROSHY ERAN | Chairman |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
50,708 |
| Bedi Arjun | Director |
May 14 '26 |
Option Exercise |
0.00 |
5,547 |
0 |
5,547 |
| CASHMAN JAMES E III | Chairman |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
484,197 |
| Killefer Nancy | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
51,846 |
| Crane Rosemary A | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
45,672 |
| WALSH MATTHEW M | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
213,316 |
| Resnick Jon Matthew | Chief Executive Officer |
May 11 '26 |
Option Exercise |
0.00 |
59,766 |
0 |
59,766 |
2.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):